Ververs T - Search Results

1

Prevalence and patterns of antidepressant drug use during pregnancy.

Ververs T, Kaasenbrood H, Visser G, Schobben F, de Jong-van den Berg L, Egberts T. Ververs T, et al. Eur J Clin Pharmacol. 2006 Oct;62(10):863-70. doi: 10.1007/s00228-006-0177-0. Epub 2006 Aug 8. Eur J Clin Pharmacol. 2006. PMID: 16896784

2

Depression during pregnancy: views on antidepressant use and information sources of general practitioners and pharmacists.

Ververs T, van Dijk L, Yousofi S, Schobben F, Visser GH. Ververs T, et al. BMC Health Serv Res. 2009 Jul 17;9:119. doi: 10.1186/1472-6963-9-119. BMC Health Serv Res. 2009. PMID: 19615056 Free PMC article.

3

Antenatal maternal antidepressants drugs treatment affects S100B levels in maternal-fetal biological fluids in a dose dependent manner.

Bellissima V, Visser GHA, Ververs T, Pluchinotta F, Varrica A, Baryshnikova E, Gabriella Tina L, Nigro F, Gavilanes D, Godos J, Gazzolo D. Bellissima V, et al. Among authors: ververs t. Clin Chim Acta. 2020 Feb;501:20-26. doi: 10.1016/j.cca.2019.11.027. Epub 2019 Dec 4. Clin Chim Acta. 2020. PMID: 31809746

4

Antenatal Maternal Antidepressants Drugs Affect S100B Concentrations in Fetal-Maternal Biological Fluids.

Bellissima V, Visser GH, Ververs TF, Bel Fv, Termote JU, Heide Mv, Gazzolo D. Bellissima V, et al. Among authors: ververs tf. CNS Neurol Disord Drug Targets. 2015;14(1):49-54. doi: 10.2174/1871527314666150116114033. CNS Neurol Disord Drug Targets. 2015. PMID: 25613501

5

Antenatal maternal antidepressants drugs affect Activin A concentrations in maternal blood, in amniotic fluid and in fetal cord blood.

Bellissima V, Visser GH, Ververs TF, van Bel F, Termote JU, van der Heide M, Florio P, Li Volti G, Gazzolo D. Bellissima V, et al. J Matern Fetal Neonatal Med. 2011 Oct;24 Suppl 2:31-4. doi: 10.3109/14767058.2011.604931. J Matern Fetal Neonatal Med. 2011. PMID: 21767104 Free article.

6

Severe valproic acid intoxication: case study on the unbound fraction and the applicability of extracorporeal elimination.

van den Broek MP, Sikma MA, Ververs TF, Meulenbelt J. van den Broek MP, et al. Eur J Emerg Med. 2009 Dec;16(6):330-2. doi: 10.1097/MEJ.0b013e32832c7b18. Eur J Emerg Med. 2009. PMID: 19424075

7

Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration.

Ververs TF, van Dijk A, Vinks SA, Blankestijn PJ, Savelkoul JF, Meulenbelt J, Boereboom FT. Ververs TF, et al. Crit Care Med. 2000 Oct;28(10):3412-6. doi: 10.1097/00003246-200010000-00006. Crit Care Med. 2000. PMID: 11057794 Clinical Trial.

8

Activated charcoal for GHB intoxication: an in vitro study.

Neijzen R, van Ardenne P, Sikma M, Egas A, Ververs T, van Maarseveen E. Neijzen R, et al. Among authors: ververs t. Eur J Pharm Sci. 2012 Dec 18;47(5):801-3. doi: 10.1016/j.ejps.2012.09.004. Epub 2012 Sep 24. Eur J Pharm Sci. 2012. PMID: 23017433

9

First Experience With 177Lu-PSMA-617 Therapy for Advanced Prostate Cancer in the Netherlands.

van Kalmthout L, Braat A, Lam M, van Leeuwaarde R, Krijger G, Ververs T, Mehra N, Bins A, Hunting J, de Keizer B. van Kalmthout L, et al. Among authors: ververs t. Clin Nucl Med. 2019 Jun;44(6):446-451. doi: 10.1097/RLU.0000000000002561. Clin Nucl Med. 2019. PMID: 30985436

10

Evaluation of available treatment guidelines for the management of lithium intoxication.

Wilting I, Egberts AC, Heerdink ER, Ververs TF, Meulenbelt J, Nolen WA. Wilting I, et al. Among authors: ververs tf. Ther Drug Monit. 2009 Apr;31(2):247-60. doi: 10.1097/FTD.0b013e318190cc26. Ther Drug Monit. 2009. PMID: 19057466

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters